370 related articles for article (PubMed ID: 21392105)
1. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla.
Xu LH; Qian JB; Gu LG; Qiu JW; Ge ZM; Lu F; Wang YM; Li YM; Lu HS
J Gastroenterol Hepatol; 2011 Jul; 26(7):1139-44. PubMed ID: 21392105
[TBL] [Abstract][Full Text] [Related]
2. Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis.
Matsushita M; Takakuwa H; Shimeno N; Uchida K; Nishio A; Okazaki K
J Gastroenterol; 2009; 44(1):71-5. PubMed ID: 19159075
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
[TBL] [Abstract][Full Text] [Related]
4. Direct spraying of shakuyakukanzoto onto the duodenal papilla: a novel method for preventing pancreatitis following endoscopic retrograde cholangiopancreatography.
Fujinami H; Kajiura S; Ando T; Mihara H; Hosokawa A; Sugiyama T
Digestion; 2015; 91(1):42-5. PubMed ID: 25632916
[TBL] [Abstract][Full Text] [Related]
5. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis.
Bailey AA; Bourke MJ; Williams SJ; Walsh PR; Murray MA; Lee EY; Kwan V; Lynch PM
Endoscopy; 2008 Apr; 40(4):296-301. PubMed ID: 18389448
[TBL] [Abstract][Full Text] [Related]
6. Effects in the control of edema of the papilla of Vater by epinephrine saline irrigation after endoscopic retrograde cholangiopancreatography in an endoscopy center in Japan, 2003 to 2007: exploratory retrospective analysis to evaluate the characteristics of eligible patients with a focus on serum amylase levels.
Nakaji K; Suzumura S; Nakae Y; Kojima K; Kumamoto M; Kozu T
Intern Med; 2009; 48(12):945-52. PubMed ID: 19525579
[TBL] [Abstract][Full Text] [Related]
7. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M
Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467
[TBL] [Abstract][Full Text] [Related]
8. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
[TBL] [Abstract][Full Text] [Related]
9. Rectal Indomethacin and Spraying of Duodenal Papilla With Epinephrine Increases Risk of Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography.
Luo H; Wang X; Zhang R; Liang S; Kang X; Zhang X; Lou Q; Xiong K; Yang J; Si L; Liu W; Liu Y; Zhou Y; Wang S; Yang M; Chen W; Han Y; Shang G; Yang X; He Y; Zou Q; Guo W; Dai Y; Zeng W; Zhu X; Gong R; Li X; Nie Z; Wang Q; Wang L; Pan Y; Guo X; Fan D
Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1597-1606.e5. PubMed ID: 30391434
[TBL] [Abstract][Full Text] [Related]
10. Clinical study on the prevention of post-ERCP pancreatitis by pancreatic duct stenting.
Pan XP; Dang T; Meng XM; Xue KC; Chang ZH; Zhang YP
Cell Biochem Biophys; 2011 Dec; 61(3):473-9. PubMed ID: 21739262
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study.
Testoni PA; Mariani A; Giussani A; Vailati C; Masci E; Macarri G; Ghezzo L; Familiari L; Giardullo N; Mutignani M; Lombardi G; Talamini G; Spadaccini A; Briglia R; Piazzi L;
Am J Gastroenterol; 2010 Aug; 105(8):1753-61. PubMed ID: 20372116
[TBL] [Abstract][Full Text] [Related]
12. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
Lee KT; Lee DH; Yoo BM
Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
[TBL] [Abstract][Full Text] [Related]
14. Needle-knife sphincterotomy: factors predicting its use and the relationship with post-ERCP pancreatitis (with video).
Bailey AA; Bourke MJ; Kaffes AJ; Byth K; Lee EY; Williams SJ
Gastrointest Endosc; 2010 Feb; 71(2):266-71. PubMed ID: 20003969
[TBL] [Abstract][Full Text] [Related]
15. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial.
Tsuchiya T; Itoi T; Sofuni A; Itokawa F; Kurihara T; Ishii K; Tsuji S; Kawai T; Moriyasu F
J Hepatobiliary Pancreat Surg; 2007; 14(3):302-7. PubMed ID: 17520207
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic injection of hypertonic saline-epinephrine oral to the papilla for prevention of postsphincterotomy bleeding.
Matsushita M; Takakuwa H; Shimeno N; Uchida K; Nishio A; Okazaki K
J Clin Gastroenterol; 2010 Sep; 44(8):e167-70. PubMed ID: 20628312
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis.
Masci E; Cavallini G; Mariani A; Frulloni L; Testoni PA; Curioni S; Tittobello A; Uomo G; Costamagna G; Zambelli S; Macarri G; Innocenti P; Dragonetti C;
Am J Gastroenterol; 2003 Oct; 98(10):2182-6. PubMed ID: 14572565
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
